Antibody-drug conjugates continue to show benefits in breast cancer, plus the FDA has fast-tracked an innovative AI tool to help identify pancreatic tumors.

Kevin Ashton, from Nevada , was diagnosed with stage four melanoma - a type of skin cancer - in September 2023 after doctors ...

A doctor who has seen first-hand the devastation skin cancer can cause is running the London Marathon to raise money for life-saving research. Dr. Ben Esdaile, a 48-year-old consultant dermatologist ...

A cancer treatment described as 'the best early Christmas present I could've asked for', has been given FDA and NICE approval.

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...

A new study led by scientists at the University of Oxford has revealed something surprising: a common virus carried by more ...

In a phase 1 trial involving 40 patients, the research group investigated the use of T cell receptor (TCR)-engineered T cells. Using genetic ...

In the Chinese mainland, toripalimab was the first domestic anti-PD-1 monoclonal antibody approved for marketing (approved in China as TUOYI®). Currently, there are twelve approved indications for ...

Researchers from the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) have applied AI-driven processes for detecting tertiary ...

Researchers from the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) have applied AI-driven processes for detecting tertiary lymphoid structures (TLS ...

Immunai will generate a publicly accessible multi-omic dataset for a Parker Institute cohort of over 1,000 cancer patients.

A novel approach to tumor-infiltrating lymphocyte therapy yielded higher response rates among patients with metastatic ...